Editas Medicine Ownership | Who Owns Editas Medicine?
Editas Medicine Ownership Summary
Editas Medicine is owned by 52.98% institutional investors, 0.35% insiders, and 46.67% retail investors. Blackrock is the largest institutional shareholder, holding 9.50% of EDIT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.12% of its assets in Editas Medicine shares.
EDIT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Editas Medicine | 52.98% | 0.35% | 46.67% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 7.78M | 9.50% | $36.34M |
Blackrock funding, inc. /de | 7.31M | 8.86% | $9.28M |
Vanguard group | 6.82M | 8.27% | $8.67M |
Millennium management | 2.75M | 3.33% | $3.49M |
Dimensional fund advisors lp | 2.16M | 2.62% | $2.74M |
State street | 1.87M | 2.27% | $2.38M |
Geode capital management | 1.81M | 2.19% | $2.30M |
Goldman sachs group | 1.79M | 2.17% | $2.27M |
Two sigma advisers, lp | 1.66M | 2.01% | $2.10M |
Two sigma investments, lp | 1.65M | 2.00% | $2.09M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Green alpha advisors | 111.63K | 0.11% | $141.77K |
Hennion & walsh asset management | 267.76K | 0.02% | $340.05K |
Kennedy capital management | 528.84K | 0.01% | $671.62K |
Dlk investment management | 25.72K | 0.01% | $32.66K |
Xtx topco | 105.06K | 0.01% | $133.42K |
Thrive wealth management | 28.50K | 0.01% | $36.20K |
Dark forest capital management lp | 32.79K | 0.01% | $41.64K |
Two sigma advisers, lp | 1.66M | 0.00% | $2.10M |
Susquehanna fundamental investments | 272.43K | 0.00% | $345.99K |
Aries wealth management | 13.85K | 0.00% | $17.59K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Renaissance | 1.45M | 0.00% | 1.45M |
Ubs group | 1.12M | 0.00% | 704.47K |
Aqr capital management | 1.07M | 0.00% | 693.96K |
Goldman sachs group | 1.79M | 0.00% | 619.01K |
Two sigma advisers, lp | 1.66M | 0.00% | 528.00K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deep track capital, lp | - | - | -4.90M |
Avidity partners management lp | - | - | -1.47M |
Balyasny asset management | - | - | -1.30M |
Pictet asset management sa | - | - | -1.16M |
Monaco asset management sam | - | - | -1.07M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Susquehanna fundamental investments | 272.43K | 0.00% | 272.43K | $345.99K |
Raymond james financial | 238.97K | 0.00% | 238.97K | $303.49K |
Acadian asset management | 193.59K | 0.00% | 193.59K | $244.00K |
Bridgeway capital management | 150.00K | 0.00% | 150.00K | $190.50K |
Sei investments | 83.16K | 0.00% | 83.16K | $105.61K |
Sold Out
Holder | Change |
---|---|
Gps wealth strategies group | -2.00 |
Pacific capital wealth advisors | -5.00 |
Sittner & nelson | -6.00 |
Baldwin brothers llc/ma | -8.00 |
Abich financial wealth management | -12.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 196 | -6.67% | 44,003,328 | -13.78% | 52 | 1.38% | 69 | -27.37% | 59 | -1.67% |
Dec 31, 2024 | 94 | -60.17% | 19,933,396 | -63.85% | 24 | 0.54% | 38 | -62.00% | 22 | -65.63% |
Sep 30, 2024 | 234 | -2.50% | 55,137,509 | -2.17% | 66 | 1.43% | 100 | -10.71% | 64 | -12.33% |
Jun 30, 2024 | 238 | 2.15% | 56,360,093 | -17.01% | 68 | 0.86% | 111 | - | 71 | 16.39% |
Mar 31, 2024 | 233 | 0.87% | 67,911,289 | 16.06% | 89 | 1.74% | 111 | 16.84% | 61 | -12.86% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 2.59M | 3.12% | - |
Vanguard Total Stock Mkt Idx Inv | 2.59M | 3.10% | - |
iShares Russell 2000 ETF | 2.12M | 2.53% | 1.04K |
Vanguard Strategic Equity Inv | 1.87M | 2.24% | 498.30K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.37M | 1.63% | - |
Pictet Biopharmaceutical Mother | 1.15M | 1.38% | 42.67K |
Selectra J. Lamarck Biotech A | 1.10M | 1.32% | 600.00K |
Vanguard Small Cap Index | 1.04M | 1.26% | 2.50K |
Fidelity Small Cap Index | 832.05K | 0.99% | - |
UBS (Lux) Digital Health Equity SB USD | 800.00K | 0.96% | -370.00K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 03, 2025 | Parison Amy | SVP, Chief Financial Officer | Sell | $768.90 |
Jun 03, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | $1.25K |
Jun 03, 2025 | O'Neill Gilmore Neil | CEO | Sell | $26.20K |
Mar 04, 2025 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | $7.03K |
Mar 04, 2025 | O'Neill Gilmore Neil | CEO | Sell | $28.45K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 3 |
2025 Q1 | - | 3 |
2024 Q4 | - | 2 |
2024 Q3 | - | 4 |
2024 Q2 | 1 | 3 |
EDIT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools